横浜市立大学大学院 医学研究科 幹細胞免疫制御内科学 血液・膠原病内科学

About教室概要

業績

2025年

膠原病グループ

原著論文: 症例報告を含む

  1. Bourguiba R, Lacombe V, Beck D, Martín-Nares E, Jachiet V, Comont T, Galland J, Heiblig M, Nguyen A, Aouba A, Boulu X, Curie A, Terrier B, Bescond C, Koster M, Kirino Y, Kosmider O, Mekinian AM, Georgin-Lavialle S. Characterizing VEXAS syndrome in women: Findings from an international multicenter study. J Intern Med. 298(5):516-524,2025.
  2. Fukui T, Naganuma M, Kirino Y, Kunisaki R, Mikami Y, Ueno N, Umeno J, Bamba S, Ooi M, Hosomi S, Matsumoto T, Matsuoka K, Watanabe C, Nagahori M, Uchino M, Watanabe K, Hirai F, Matsuura M, Tanaka Y, Takeno M, Hisamatsu T. A Multicenter Observational Study for the Establishment of Novel Severity Criteria Including Endoscopic Evaluation for Intestinal Behçet’s Disease. Dig Endosc. 38(1):e70041,2025.
  3. Geetha D, Cortazar FB, Bruchfeld A, Kronbichler A, Karras A, Nakhoul GN, Merkel PA, Bray S, Bozeman AM, Jayne DRW; ADVOCATE Study Group (Kirino Y). Treatment With Avacopan in ANCA-Associated Vasculitis With Kidney Involvement. Kidney Int Rep. 10(8):2751-2765, 2025.
  4. Geetha D, Neumann T, Karras A, Cid MC, Merkel PA, Bray S, Bozeman AM, Jayne DRW; Members of the ADVOCATE Study Group (Kirino Y). Efficacy and safety of avacopan for treatment of patients with ANCA-associated vasculitis receiving cyclophosphamide. RMD Open. 11(4):e005743,2025.
  5. Haraguchi Hashiguchi M, Yoshimi R, Ozawa T, Asaoka M, Kagyo J, Kawahara Y, Shiomi T: Idiopathic Interstitial Lung Disease with Positive Anti-Zo and Anti-Ro52/SSA1 Antibodies. Intern Med. 64(20):2990-2994,2025.
  6. Ichikawa K, Adachi S, Takase-Minegishi K, Nakayama Y, Nagasawa Y, Iizuka Y, Maeda A, Hirahara L, Soejima Y, Ohashi T, Kunimoto H, Horita N, Yoshimi R, Kirino Y, Nakajima H: Distinct features of trisomy 8-associated autoinflammatory disease from Behçet’s disease: case series and systematic review. Clin Exp Rheumatol. 43(10):1718-1725,2025.
  7. Ichikawa K, Kunishita Y, Shinoda S, Harita K, Honda C, Suzuki N, Higashitani K, Iizuka Y, Uzawa Y, Ohno E, Hidekawa C, Komiya T, Sakurai N, Sato Y, Mitsuhashi M, Hamada N, Yoshioka Y, Tsuchida N, Maeda A, Hirahara L, Soejima Y, Kishimoto D, Nakano H, Takase-Minegishi K, Yoshimi R, Kirino Y, Okubo T, Ohno S, Nagaoka S, Nakajima H: Comparative effectiveness and safety of peficitinib and abatacept for rheumatoid arthritis: a multicentre, inverse probability weighting analysis. Mod Rheumatol. 2026;36(2):196-204.
  8. Ichikawa T, Kishida D, Shimojima Y, Yajima N, Oguro N, Yoshimi R, Sakurai N, Hidekawa C, Sada KE, Miyawaki Y, Hayashi K, Shidahara K, Ishikawa Y, Sekijima Y, Kurita N: Trust in Health Information Sources Among Patients With Systemic Lupus Erythematosus in the Social Networking Era: The TRUMP2-SLE Study. J Rheumatol. 52(10):1005-1012,2025.
  9. Ishikawa Y, Oguro N, Ichikawa T, Kishida D, Sakurai N, Hidekawa C, Shidahara K, Hayashi K, Miyawaki Y, Shimojima Y, Yoshimi R, Sada KE, Yajima N, Kurita N: Association between sleep-disordered breathing and moderate to severe depression in systemic lupus erythematosus: the TRUMP2-SLE study. Mod Rheumatol. 35(6):952-958,2025.
  10. Ishizuka K, Shikino K, Takada N, Sakai Y, Ototake Y, Kobayashi T, Inoue T, Jikuya R, Iwata Y, Nishimura K, Yoshimi R, Oi Y, Watanabe Y, Togashi Y, Ogawa F, Sano D, Asami T, Imai Y, Takeuchi I, Funakoshi K, Ohta M, Inamori M, Kusakabe A: Enhancing clinical reasoning skills in medical students through team-based learning: a mixed-methods study. BMC medical education. 25(1):221,2025.
  11. Kashino K, Tsuchida N, Maeda A, Uchiyama Y, Kirino Y, Matsumoto N, Hamada T. VEXAS syndrome initially presenting as relapsing polychondritis and progressing into neutrophilic dermatosis with systemic symptoms over a 5-year period. Int J Dermatol. 64(7):1307-1309,2025.
  12. Kirino Y, Maeda A, Asano T, Migita K, Hidaka Y, Ida H, Kobayashi D, Oda N, Rokutanda R, Fujieda Y, Atsumi T, Kishida D, Kobayashi H, Shiratsuchi M, Shimizu T, Kawakami A, Tanaka K, Tsuji T, Mishima K, Miyamae T, Hasegawa A, Ikeda K, Watanabe T, Yamaguchi Y, Nishikomori R, Ohara O, Nakajima H; Japan VEXAS Study Group. Low remission rates and high incidence of adverse events in a prospective VEXAS syndrome registry. Rheumatology (Oxford). 64(6):3872-3878,2025.
  13. Lee C, Takeuchi M, Kawagoe T, Nakamura J, Shibuya E, Ishihara M, Yamada N, Mizuki Y, Meguro A, Kirino Y, Soejima Y, Hirahara L, Iizuka Y, Mizuki N. Effectiveness and safety of biosimilar infliximab CT-P13 in the treatment of refractory uveitis associated with Behçet’s disease. Jpn J Ophthalmol. 69(5):798-804,2025.
  14. Maeda A, Kirino Y, Tsuchida N, Uchiyama Y, Kobayashi D, Asano T, Ito Y, Katsuo K, Kato A, Mori I, Yamaguchi H, Shimizu T, Kobayashi S, Kishimoto M, Oda N, Rokutanda R, Nagahata K, Fujiwara H, Kobayashi H, Takeuchi Y, Hagiyama H, Umeda N, Uchino K, Miyoshi Y, Hidaka Y, Ida H, Akasaka K, Kashino K, Yoshida Y, Ohnishi H, Takahashi N, Fujieda Y, Horita N, Takase-Minegishi K, Matsumoto N, Nakajima H. High glucocorticoid dependency and limited therapeutic response in Japanese patients with VEXAS syndrome: a multicentre retrospective study. Mod Rheumatol. 36(2):307-312, 2026.
  15. Matsuoka N, Yajima N, Inoue E, Sato S, Ogawa S, Sumichika Y, Saito K, Yoshida S, Matsumoto H, Temmoku J, Fujita Y, Asano T, Fukita J, Sada KE, Ichinose K, Yoshimi R, Ohno S, Kajiyama H, Shimojima Y, Fujiwara M, Kida T, Miyawaki Y, Matsuo Y, Onishi T, Nishimura K, Migita K: Safety of mycophenolate mofetil in systemic lupus erythematosus maintenance therapy: insights from the LUNA registry in a nationwide prospective cohort study. RMD Open. 11(3):e005558,2025.
  16. Miyagi Y, Kobayashi H, Umebayashi Y, Okimura A, Nakatsugawa M, Maeda A, Kirino Y, Aoki A. A Japanese case of VEXAS syndrome after COVID-19 vaccination: Comparison with previously reported cases. Mod Rheumatol Case Rep. 9(1):218-223,2025.
  17. Miyamae T, Manabe Y, Sugihara T, Umezawa N, Yoshifuji H, Tamura N, Abe Y, Furuta S, Nagafuchi H, Ishizaki J, Nakano N, Atsumi T, Karino K, Amano K, Kurasawa T, Ito S, Yoshimi R, Ogawa N, Banno S, Naniwa T, Ito S, Hara A, Hirahara S, Uchida HA, Onishi Y, Murakawa Y, Komagata Y, Nakaoka Y, Harigai M: Pregnancy and childbirth in Takayasu arteritis in Japan: A nationwide retrospective study. Mod Rheumatol. 35(2):339-344,2025.
  18. Mizuki Y, Horita N, Takeno M, Meguro A, Kirino Y, Kawagoe T, Sakono T, Ishihara M, Ohno S, Mizuki N. Epidemiological and clinical insights into Behçet’s disease in Japan: a 2019 nationwide analysis. Mod Rheumatol. 36(3):422-429, 2026.
  19. Morishita S, Sada KE, Kudo M, Dobashi N, Sasaki S, Yoshimi R, Sakurai N, Hidekawa C, Shimojima Y, Kishida D, Ichikawa T, Miyawaki Y, Hayashi K, Shidahara K, Ishikawa Y, Oguro N, Yajima N, Kurita N, Suganuma N: Association of physicians’ Big Five personality traits with shared decision-making in patients with SLE. Rheumatology (Oxford). 64(10):5269-5276,2025.
  20. Nagasawa Y, Takase-Minegishi K, Adachi S, Ichikawa K, Nagai H, Watanabe T, Yamaguchi Y, Yoshimi R, Kirino Y, Nakajima H: Successful re-administration of tocilizumab in a patient with adult-onset Still’s disease after improvement of macrophage activation syndrome. Mod Rheumatol Case Rep. 9(2):rxaf020,2025.
  21. Specks U, Spiera RF, Fussner LA, Lebovics R, Bray S, Gurlin RE, Trimpe D, Jayne DRW, Merkel PA; ADVOCATE Study Group (Kirino Y). Treatment With Avacopan in Patients With Respiratory Tract Manifestations of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. ACR Open Rheumatol. 7(1):e11795,2025.
  22. Sugimoto S, Shimojima Y, Kishida D, Ichikawa T, Takamatsu R, Yajima N, Ichinose K, Shimizu T, Yoshimi R, Kida T, Katsuyama T, Matsuo Y, Kajiyama H, Takatani A, Sekijima Y: Implications of serum calcitonin gene-related peptide and type I interferon in systemic lupus erythematosus-associated headaches. Lupus. 34(6):608-616,2025.
  23. Takase-Minegishi K, Böhringer S, Nam JL, Kaneko Y, Behrens F, Saevarsdottir S, Detert J, Leirisalo-Repo M, van der Heijde D, Landewé R, Ramiro S, van der Woude D: The impact of autoantibodies on the efficacy of biological disease-modifying anti-rheumatic drugs in rheumatoid arthritis: meta-analysis of randomized controlled trials. Rheumatology (Oxford). 64(2):548-560,2025.

ページトップへ